The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Open accessAbstract
Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD + with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD + metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD + , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD + repletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NAM, in contrast, is a well reported and widely used sirtuin inhibitor31 and has been recently shown to inhibit NAD+-consuming activities in vivo24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In another study, NAAD was not detected in human blood prior to NR supplementation, while there was a ∼2,900% increase in NAAD baseline in healthy individuals taking single doses of up to 1 g NR (100, 300, and 1000 mg) [63].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“It is still unclear why NR administration increases NAD+ levels more than NAM and NA treatment [63], while NMN and NAM administration showed no difference in NAD levels in blood and liver [90].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, by LC-tandem MS and with the use of internal standards, the baseline concentrations of hepatic NMN and NAD+ were determined to be ∼2 and ∼1,000 pmol mg−1, respectively, rising to ∼10 and ∼4,000 pmol mg−1, respectively, 6 h after oral gavage of 185 mg kg−1 NR24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“This concept was established by a recent study in which orally administered equimolar NAM, NR and NA produced unique effects on hepatic NAD+ metabolism through distinct biosynthetic routes24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 126
RetractedDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Research works printed but not linked: 1
- Altman, L. K. Who Goes First: The Story of Self-experimentation in Medicine University of California Press (1987).
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Xiao, W., Wang, R.-S., Handy, D. E., & Loscalzo, J. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7216 · Cited by 1,061
“A recent study reported that oral NR supplementation is bioavailable for NAD biosynthesis in healthy volunteers and that NR exhibits unique and superior pharmacokinetics compared to NA and NAM in mice (128).”
BackgroundNAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
“NR also protects against diabetic and chemotherapy-induced neuropathy in mice (Hamity et al., 2017; Trammell et al., 2016b), raising hopes that it could have a role in the management of chronic pain.”
InfluentialPersonalized medicine: motivation, challenges, and progress
Goetz, L. H., & Schork, N. J. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.006 · Cited by 976
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 923
“Prior studies also showed that NR was safe and well tolerated in normal individuals (159, 160).”
Background
Metadata
- Authors
- Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Queen's University Belfast (GB)
- ChromaDex (United States) (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-10
- Volume
- 7
- Issue
- 1
- Pages
- 12948-12948
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5062546
- OpenAlex
- W2530388030
- Cited by
- 697
- References
- 57
- Citations by year
- 2026: 73 · 2025: 72 · 2024: 63 · 2023: 73 · 2022: 80 · 2021: 89 · 2020: 73 · 2019: 70 · 2018: 58 · 2017: 40 · 2016: 2
- FWCI
- 32.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- Roy J. Carver Charitable Trust
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- nicotinamide riboside, NAD+ metabolism, oral bioavailability, pharmacokinetics, nicotinic acid, nicotinamide, dose-dependent effects
- MeSH terms
- Administration, Oral, Animals, Biological Availability, Humans, Leukocytes, Mononuclear, Liver, Male, Mice, Inbred C57BL, Middle Aged, NAD, Niacinamide, Pyridinium Compounds, Vitamins, Biomarkers, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. https://app.cochat.ai/papers/10.1038/ncomms12948
- The paper
- Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. https://doi.org/10.1038/ncomms12948
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.